Keyphrases
Ulcerative Colitis
100%
Enhanced Production
100%
Prednisolone
100%
Activity Inhibition
100%
Active Disease
100%
Platelet-activating Factor
100%
Sulfasalazine
100%
Immunoglobulin E
42%
A23187
42%
Active Ulcerative Colitis
28%
Normal mucosa
28%
5-aminosalicylic Acid (5-ASA)
28%
Ethanol
14%
Therapeutic Effect
14%
Phospholipase
14%
Thin Layer Chromatography
14%
Neutrophils
14%
Biopsy Specimen
14%
Inflammatory Response
14%
Ischemia
14%
Inflammatory Cells
14%
Mucosal Ulcers
14%
Calcium Ionophore A23187
14%
Colon Biopsy
14%
Aggregation Assay
14%
Sulfapyridine
14%
Secondary Messengers
14%
Medicine and Dentistry
Disease
100%
Ulcerative Colitis
100%
Platelet-Activating Factor
100%
Prednisolone
100%
Salazosulfapyridine
100%
A23187
57%
Immunoglobulin E
42%
Mucosa
28%
4-Aminosalicylic Acid
28%
Serositis
14%
Epileptic Absence
14%
Inflammatory Cell
14%
Neutrophil
14%
Ischemia
14%
Buffer
14%
Venous Ulcer
14%
Alcohol
14%
Therapy Effect
14%
Colon Biopsy
14%
Thin-Layer Chromatography
14%
Sulfapyridine
14%
Phospholipase
14%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Prednisolone
100%
Ulcerative Colitis
100%
Thrombocyte Activating Factor
100%
Sulfasalazine
100%
Calcimycin
57%
Immunoglobulin E
42%
Aminosalicylic Acid
28%
Inflammation
14%
Epileptic Absence
14%
Phospholipase
14%
Buffer
14%
Therapeutic Effect
14%
Ischemia
14%
Ulcer
14%
Sulfapyridine
14%
Immunology and Microbiology
Ulcerative Colitis
100%
Prednisolone
100%
Thrombocyte Activating Factor
100%
Sulfasalazine
100%
Immunoglobulin E
42%
Mucosa
28%
Thin-Layer Chromatography
14%
Inflammatory Cell
14%
Neutrophil Granulocyte
14%
Inflammation Response
14%